Rhoen-Klinikum AG
Rhoen-Klinikum AG (RHK.SW) Stock Overview
Explore Rhoen-Klinikum AG’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
796.3M
P/E Ratio
65.48
EPS (TTM)
$0.36
ROE
0.02%
RHK.SW Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Rhoen-Klinikum AG (RHK.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $25.56.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 65.48 and a market capitalization of 796.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.